You have been chosen to receive this valuable information.
Agilent Technologies | Trusted Answers
Ultra-Fast High Res LC-MS Analysis in Forensic Tox Testing

Ultra-Fast high Res LC-MS Analysis in Forensic Toxicology

The analysis of drugs in forensic toxicology is inherently complex, especially since the advent of novel psychoactive substances such as substituted cathinones and synthetic cannabinoids and, more recently, the problem of non-pharmaceutical fentanyls. Traditional methods for drugs of abuse analysis involving immunoassays and even some chromatographic techniques are not always ideally suited to detecting these compounds and/or their possible metabolites.

This webinar summarizes how the combination of Q-TOF mass spectrometry and ultra-high speed (sub-1 minute) chromatography can be utilized in both targeted analyses and screening applications for forensic toxicology.

Learning objectives:

1.

Learn how you can use short LC columns and rapid gradients to achieve ultra-rapid chromatographic analysis

2.

Understand how Q-TOF mass spectrometry is suited to (i) ultra-rapid analysis and (ii) screening for the most modern abused drugs

3.

How well-curated Q-TOF mass spectral libraries are used for forensic toxicology screening

Speaker:

Dr. Lewis Couchman, Ph.D.

Dr. Lewis Couchman, Ph.D.
Facility Director,
Analytical Services International Ltd.,
University of London

Register now

For Forensic Use

Agilent Home  |  About Agilent  |  Legal  |  Subscriptions

5301 Stevens Creek Blvd, Santa Clara CA 95051, USA

Agilent is committed to respecting and protecting your privacy. To view the promises that we make to you regarding your personal information, please view Agilent's privacy statement. For questions related to privacy, please send your inquiry to privacy_advocate@agilent.com. If you prefer not to receive promotional e-mails from Agilent in the future, you can unsubscribe at any time. You can also update your e-mail address, contact information, or interest profile to ensure you receive the most relevant information.

Facebook Twitter LinkedIn Youtube

ⓒ Agilent Technologies, Inc. 2018

View this email in web or text

 
 
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of LCGC, a UBM publication. You are on the mailing list as %%emailaddress%%.